Thermo Fisher Scientific (TMO) – StreetInsider.com Reports
-
Thermo Fisher Scientific (TMO) PT Raised to $650 at Morgan Stanley
-
Thermo Fisher Scientific (TMO) PT Raised to $650 at JPMorgan
-
Thermo Fisher Scientific (TMO) PT Lowered to $620 at Baird
-
Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank
-
Thermo Fisher Scientific (TMO) PT Raised to $615 at Barclays
-
Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
-
Thermo Fisher lifts profit forecast as medical equipment demand improves
-
Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations
-
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance
-
Thermo Fisher Scientific (TMO) PT Raised to $621 at Baird
-
Repligen (RGEN), Danaher (DHR) Weakness Tied to Results From Sartorius AG
-
Thermo Fisher Scientific (TMO) PT Raised to $640 at Goldman Sachs
-
CFRA Upgrades Thermo Fisher Scientific (TMO) to Buy
-
Citi Resumes Thermo Fisher Scientific (TMO) at Neutral
-
Evercore Positive on a these names following 'China stimulus for hospital & teaching equipment'
-
Thermo Fisher Scientific (TMO) Raises Quarterly Dividend 11.4% to $0.39; 0.3% Yield
-
Accountability Research Downgrades Thermo Fisher Scientific (TMO) to Hold
-
Thermo Fisher Scientific (TMO) PT Raised to $612 at TD Cowen
-
Thermo Fisher Scientific (TMO) PT Raised to $650 at UBS
-
Thermo Fisher Scientific (TMO) PT Raised to $642 at RBC Capital
-
Thermo Fisher Scientific (TMO) PT Lowered to $597 at Baird
-
Thermo Fisher Scientific (TMO) PT Raised to $600 at Deutsche Bank
-
Thermo Fisher Scientific (TMO) PT Raised to $590 at Barclays
-
Thermo Fisher Scientific (TMO) PT Raised to $540 at Jefferies
-
Thermo Fisher Scientific (TMO) PT Raised to $575 at Evercore ISI
-
Midday movers: Boeing flies, Alphabet flops, and more
-
Thermo Fisher (TMO) falls as 2024 guidance trails analyst estimates
-
Thermo Fisher forecasts 2024 below estimates, cautious on biotech demand
-
Thermo Fisher Scientific (TMO) Tops Q4 EPS by 3c, Beats on Revenue; Offers Guidance
-
Thermo Fisher Scientific (TMO) February weekly option implied volatility elevated into quarter results
-
Thermo Fisher Scientific (TMO) February weekly 555 straddle into quarter results
-
Nephron Upgrades Thermo Fisher Scientific (TMO) to Buy
-
Thermo Fisher Scientific (TMO) PT Raised to $609 at Baird
-
Midday movers: Intel falls, American Express climbs
-
Barclays Downgrades Thermo Fisher Scientific (TMO) to Equalweight
-
Bernstein Downgrades Thermo Fisher Scientific (TMO) to Market Perform
-
Galapagos (GLPG) enters into strategic collaboration agreement with Thermo Fisher Scientific (TMO)
-
UnitedHealth and AbbVie 2 of several pharma names cut at HSBC
-
Thermo Fisher Scientific (TMO) PT Raised to $565 at Deutsche Bank
-
HSBC Starts Thermo Fisher Scientific (TMO) at Buy, 'one of the best execution stories in the sector'
-
Thermo Fisher Scientific (TMO) PT Raised to $640 at UBS
-
Wolfe Research Starts Thermo Fisher Scientific (TMO) at Outperform
-
Thermo Fisher Scientific (TMO) PT Raised to $575 at Citi
-
Thermo Fisher Scientific (TMO) Authorizes $4 Billion of Share Repurchases
-
Thermo Fisher Scientific (TMO) Declares $0.35 Quarterly Dividend; 0.3% Yield
-
Thermo Fisher Scientific (TMO) PT Raised to $550 at Argus
-
Novo Nordisk Has Hired Fujifilm Diosynth Biotechnologies To Fill Wegovy Injection Pens - Reuters
-
Thermo Fisher Scientific (TMO) Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink (OLK)
-
Thermo Fisher Scientific (TMO) PT Lowered to $510 at UBS
-
Thermo Fisher Scientific (TMO) PT Lowered to $530 at TD Cowen
Back to TMO Stock Lookup